Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey

Joint Bone Spine

Volumn 75, Issue 3, 2008, Pages 299-302

  Gunal, Esen Kasapoglu ^a   Sarvan, Fatma Oguz ^b   Kamali, Sevil ^b   Gul, Ahmet ^b   Inanc, Murat ^b   Carin, Mahmut ^b   Konice, Meral ^b   Aral, Orhan ^b   Ocal, Lale ^b  

^a MALTEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; HLA B27; HLA B27 alleles

Indexed keywords

HLA B27 ANTIGEN;

ADULT; AGED; ALLELE; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HERITABILITY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SAMPLE SIZE; SEX RATIO; SYMPTOM; TURKEY (REPUBLIC); UVEITIS;

FEMALE; GENE FREQUENCY; HLA-B27 ANTIGEN; HUMANS; MALE; SPONDYLITIS, ANKYLOSING; TURKEY;

EID: 42749094934     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.06.021     Document Type: Article

References (22)

1. Khan M.A. HLA-B27 polymorphism and association with disease. J Rheumatol 27 (2000) 1110-1114
2. Khan M.A. Clinical features of ankylosing spondylitis. In: Hochberg M.C., Silman A.J., Smolen J.S., Weinblatt M.E., and Weisman M.H. (Eds). Rheumatology (2003), Mosby, Edinburgh 1161-1183
3. Ball E.J., and Khan M.A. HLA-B27 polymorphism. Joint Bone Spine 68 (2001) 378-382
4. Arnas J.B., Gonzales S., Martinez-Borra J., et al. Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles. Tissue Antigens 53 (1999) 237-243
5. Hemmatpour S.K., Dunn P.P., Evans P.R., et al. Functional characterization and exon 2-intron 2-exon 3 gene sequence of HLA-B*2712 as found in British family. Eur J Immunogenet 25 (1998) 395-402
6. Fraile A., Martin J., Lopez-Nevot M.A., et al. HLA-B*27 subtyping by PCR-RFLP in Spanish patients with ankylosing spondylitis. Tissue Antigens 52 (1998) 492-496
7. Lopez-Larrea C., Gonzalez S., and Martinez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondyloarthropathy. Mol Med Today 4 (1998) 540-549
8. Lopez-Larrea C., Sujirachato K., Mehra N.K., et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Tissue Antigens 45 (1995) 169-176
9. Linden V.d., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27 (1984) 361-367
10. Oguz F.S., Ocal L., Diler A.S., et al. HLA-B27 subtypes in Turkish patients with spondyloarthropathy and healthy controls. Dis Markers 20 (2004) 309-312
11. Gül A., Uyar F.A., İnanç M., et al. A weak association of HLA-B*2702 with Behçet's disease. Genes Immun 3 (2002) 368-372
12. Feldtkeller E., Khan M.A., Heijde V.d., et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23 (2003) 61-66
13. Rivera S., Hassanhi M., Marquez C., et al. Relation of spondyloarthropathy and HLA-B27 antigen in patients from the state of Zulia, Venezuala. Sanger (Barc) 41 (1996) 473-476
14. Hamersma J., Cardon L.R., Bradbury L., et al. Is disease severity in ankylosing spondylitis genetically determined?. Arthritis Rheum 44 (2001) 1396-1400
15. Brown M.A., Brophy S., Bradbury L., et al. Identificationof major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 48 (2003) 2234-2239
16. Khan M.A. Update on spondyloarthropathies. Ann Intern Med 136 (2002) 896-897
17. Will R., Edmonds L., Elswood J., et al. Is there sexual inequality in ankylosing spondylitis? A study of 498 women 1202 men. J Rheumatol 17 (1990) 1649-1652
18. Alamanos Y., Papadopoulos N.G., Voulgari P.V., et al. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology 43 (2004) 615-618
19. Breban M., Miceli-Richard C., Zinovieva E., et al. The genetics of spondyloarthropathies. Joint Bone Spine 73 (2006) 355-362
20. Gül A. Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4 (2005) 81-83
21. Lachmann H.J., Sengul B., Yavuzsen T.U., et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology 45 (2006) 746-750
22. Cipriani A., Rivera S., Hassanhi M., et al. HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol 64 (2003) 745-749